Ryght AI, a startup using agentic AI to automate clinical trials, raised a $3 million seed round, co-founder and CEO Simon Arkell tells Axios Pro exclusively.
Ryght AI, a startup using agentic AI to automate clinical trials, raised a $3 million seed round, co-founder and CEO Simon Arkell tells Axios Pro exclusively.
Read more on Axios.
Synthetica Bio taps into generative AI and strategic partnerships to revolutionize drug discovery. This innovation aims to empower biopharma...
Ryght AI partners with USC’s Keck School of Medicine to launch a global clinical trial network, streamlining trials with AI for faster patient care.
Discover how leading sponsors and CROs are using AI to identify and engage the perfect research sites for their protocols in minutes, not months in...